Vyxeos 44 MG / 100 MG Liposome Injection
ITCC-092
Phase 1 small_molecule active
Quick answer
Vyxeos 44 MG / 100 MG Liposome Injection for Relapsed Pediatric AML is a Phase 1 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Relapsed Pediatric AML
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active